 |
FSD Pharma
HUGE
|
-2.15 |
- |
5743.5 % |
$ 69.7 M |
Canada |
 |
MorphoSys AG
MOR
|
-0.612 |
- |
2.43 % |
$ 254 M |
Germany |
 |
Happiness Biotech Group Limited
HAPP
|
-0.183 |
- |
1.35 % |
$ 17.8 M |
China |
 |
AgeX Therapeutics
AGE
|
5.53 |
- |
-10.17 % |
$ 12.2 K |
USA |
 |
I-Mab
IMAB
|
-0.236 |
- |
- |
$ 866 M |
China |
 |
Deciphera Pharmaceuticals
DCPH
|
-6.15 |
- |
- |
$ 2.18 B |
USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
55.7 |
- |
- |
$ 40.3 B |
USA |
 |
Genfit SA
GNFT
|
2.49 K |
- |
2.54 % |
$ 160 B |
France |
 |
Biophytis SA
BPTS
|
-10.5 |
- |
-13.47 % |
$ 169 M |
France |
 |
AstraZeneca PLC
AZN
|
16.3 |
- |
- |
$ 96.9 B |
Britain |
 |
BioNTech SE
BNTX
|
-19.4 |
$ 89.59 |
- |
$ 21.7 B |
Germany |
 |
Compugen Ltd.
CGEN
|
5.55 |
$ 2.22 |
- |
$ 207 M |
Israel |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.57 |
- |
-1.52 % |
$ 24.7 M |
USA |
 |
Coherus BioSciences
CHRS
|
1.35 |
$ 1.58 |
- |
$ 185 M |
USA |
 |
Athira Pharma
ATHA
|
-0.0167 |
- |
- |
$ 269 M |
USA |
 |
BiondVax Pharmaceuticals Ltd.
BVXV
|
-18.5 |
- |
0.74 % |
$ 768 M |
Israel |
 |
Abcam plc
ABCM
|
-581 |
- |
- |
$ 4.9 B |
Britain |
 |
Galera Therapeutics
GRTX
|
-0.403 |
- |
-32.59 % |
$ 7.61 M |
USA |
 |
Midatech Pharma plc
MTP
|
-251 |
- |
-18.52 % |
$ 27.3 M |
Britain |
 |
Affimed N.V.
AFMD
|
-9.16 |
- |
-34.95 % |
$ 21.5 M |
Germany |
 |
Институт стволовых клеток человека
ISKJ
|
38.8 |
- |
- |
- |
Russia |
 |
Checkmate Pharmaceuticals
CMPI
|
-0.859 |
- |
- |
$ 231 M |
USA |
 |
Celyad Oncology SA
CYAD
|
-0.259 |
- |
- |
$ 12.5 M |
Belgium |
 |
Berkeley Lights
BLI
|
-1.19 |
- |
-7.31 % |
$ 87 M |
USA |
 |
Celldex Therapeutics
CLDX
|
-7.88 |
$ 29.93 |
- |
$ 1.99 B |
USA |
 |
Generation Bio Co.
GBIO
|
-1.41 |
- |
- |
$ 344 M |
USA |
 |
IMV
IMV
|
-0.18 |
- |
- |
$ 13.1 M |
Canada |
 |
Akero Therapeutics
AKRO
|
-12.9 |
- |
- |
$ 3.67 B |
USA |
 |
Akouos
AKUS
|
-2.12 |
- |
0.23 % |
$ 488 M |
USA |
 |
Enlivex Therapeutics Ltd.
ENLV
|
0.0355 |
$ 0.79 |
- |
$ 36.1 M |
Israel |
 |
Ayala Pharmaceuticals
AYLA
|
-0.203 |
- |
- |
$ 7.46 M |
Israel |
 |
Esperion Therapeutics
ESPR
|
-24.7 |
$ 3.13 |
- |
$ 651 M |
USA |
 |
Eton Pharmaceuticals
ETON
|
-121 |
$ 28.9 |
- |
$ 778 M |
USA |
 |
Cyclacel Pharmaceuticals
CYCCP
|
0.00975 |
- |
-4.36 % |
$ 27 M |
USA |
 |
Freeline Therapeutics Holdings plc
FRLN
|
-2.93 |
- |
- |
$ 384 M |
Britain |
 |
Forte Biosciences
FBRX
|
-4.83 |
$ 16.69 |
- |
$ 216 M |
USA |
 |
Gracell Biotechnologies
GRCL
|
-4.4 |
- |
- |
$ 3.37 B |
China |
 |
Anika Therapeutics
ANIK
|
-19.7 |
$ 14.79 |
- |
$ 212 M |
USA |
 |
Advaxis
ADXS
|
-0.0388 |
- |
-9.65 % |
$ 45.9 M |
USA |
 |
Aeterna Zentaris
AEZS
|
-0.964 |
- |
5.93 % |
$ 314 M |
Canada |
 |
Aeglea BioTherapeutics
AGLE
|
-3.48 |
- |
- |
$ 1.01 B |
USA |
 |
CureVac N.V.
CVAC
|
-8.58 |
- |
- |
$ 867 M |
Germany |
 |
Applied Genetic Technologies Corporation
AGTC
|
-0.735 |
- |
- |
$ 26.5 M |
USA |
 |
AIkido Pharma
AIKI
|
-1.33 |
- |
1.93 % |
$ 17.4 M |
USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
-0.489 |
$ 3.16 |
- |
$ 5.2 M |
Israel |
 |
Aptose Biosciences
APTO
|
-0.0913 |
- |
-45.71 % |
$ 1.2 M |
Canada |
 |
CRISPR Therapeutics AG
CRSP
|
-7.54 |
$ 56.95 |
- |
$ 5.12 B |
Schweiz |
 |
Aptinyx
APTX
|
-0.146 |
- |
-39.0 % |
$ 4.57 M |
USA |
 |
Albireo Pharma
ALBO
|
-16.1 |
- |
-0.23 % |
$ 916 M |
USA |
 |
Galectin Therapeutics
GALT
|
-5.78 |
$ 2.38 |
- |
$ 152 M |
USA |